AT267589T - A composition with controlled active ingredient release - Google Patents

A composition with controlled active ingredient release

Info

Publication number
AT267589T
AT267589T AT99911627T AT99911627T AT267589T AT 267589 T AT267589 T AT 267589T AT 99911627 T AT99911627 T AT 99911627T AT 99911627 T AT99911627 T AT 99911627T AT 267589 T AT267589 T AT 267589T
Authority
AT
Austria
Prior art keywords
composition
active ingredient
ingredient release
controlled active
controlled
Prior art date
Application number
AT99911627T
Other languages
German (de)
Inventor
Daniel Bar-Shalom
Original Assignee
Egalet As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP98610009 priority Critical
Application filed by Egalet As filed Critical Egalet As
Priority to PCT/DK1999/000174 priority patent/WO1999051208A1/en
Publication of AT267589T publication Critical patent/AT267589T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules, nanotubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
AT99911627T 1998-04-03 1999-03-25 A composition with controlled active ingredient release AT267589T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP98610009 1998-04-03
PCT/DK1999/000174 WO1999051208A1 (en) 1998-04-03 1999-03-25 Controlled release composition

Publications (1)

Publication Number Publication Date
AT267589T true AT267589T (en) 2004-06-15

Family

ID=8235847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99911627T AT267589T (en) 1998-04-03 1999-03-25 A composition with controlled active ingredient release

Country Status (10)

Country Link
US (1) US7883722B2 (en)
EP (1) EP1067910B1 (en)
JP (1) JP4533531B2 (en)
AT (1) AT267589T (en)
AU (1) AU3024399A (en)
CA (1) CA2327685C (en)
DE (1) DE69917618T2 (en)
DK (1) DK1067910T3 (en)
ES (1) ES2221370T3 (en)
WO (1) WO1999051208A1 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4533531B2 (en) 1998-04-03 2010-09-01 ビーエム リサーチ エイ/エスBm Research A/S Controlled release composition
DK1429734T3 (en) 2001-09-21 2008-05-13 Egalet As Solid dispersions of carvedilol for controlled release
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
GB0222612D0 (en) * 2002-09-30 2002-11-06 Univ Gent Controlled delivery system for bioactive substances
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8298581B2 (en) 2003-03-26 2012-10-30 Egalet A/S Matrix compositions for controlled delivery of drug substances
WO2004041252A1 (en) * 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
WO2004093843A1 (en) 2003-04-24 2004-11-04 Jagotec Ag Delayed release tablet with defined core geometry
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Anti-abuse dosage form
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
JP2008509933A (en) * 2004-08-13 2008-04-03 エミスフェアー・テクノロジーズ・インク Pharmaceutical formulation comprising microparticles or nanoparticles of a delivery agent
DE102004043863A1 (en) 2004-09-10 2006-03-16 Nitec Pharma Ag Tablets with local and time-controlled drug release in the gastrointestinal tract
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
NZ555693A (en) * 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Break-resistant dosage forms with sustained release
CN101188999B (en) * 2005-06-03 2012-07-18 尹格莱特股份有限公司 A pharmaceutical delivery system for delivering active component dispersed in dispersion medium
JP2009545546A (en) 2006-08-03 2009-12-24 ニテック ファーマ アクチエンゲゼルシャフトNitec Pharma AG Delayed release glucocorticoid treatment for rheumatic diseases
EP1920767A1 (en) * 2006-11-09 2008-05-14 Abbott GmbH & Co. KG Melt-processed imatinib dosage form
NZ577560A (en) * 2007-01-16 2012-01-12 Egalet Ltd Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
TWI454288B (en) 2008-01-25 2014-10-01 Gruenenthal Chemie Pharmaceutical dosage form
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
ES2599031T3 (en) 2008-05-09 2017-01-31 Grünenthal GmbH Process for the preparation of an intermediate powder formulation and a final solid dosage form using a spray freezing step
US20110142905A1 (en) * 2008-08-14 2011-06-16 Bioneer A/S Coated tablets with remaining degradation surface over the time
ES2607209T3 (en) 2009-02-06 2017-03-29 Egalet Ltd. Abuse resistant pharmaceutical compositions
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
BRPI1010550B1 (en) * 2009-05-13 2019-11-05 Basf Se dosage forms, and process for producing preparations for dosage forms of poorly water-soluble active substances
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
WO2011009603A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Tamper-resistant dosage form for oxidation-sensitive oploids
US10080721B2 (en) 2009-07-22 2018-09-25 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
TW201132646A (en) * 2010-02-22 2011-10-01 Daiichi Sankyo Co Ltd Oral solid extended release dosage form
RU2012143739A (en) 2010-03-15 2014-04-20 Ферросан Медикал Дивайсиз А/С Method for accelerating the stop of bleeding and / or healing of the ras
JP5993368B2 (en) 2010-05-12 2016-09-14 スペクトラム ファーマシューティカルズ インコーポレイテッド Lanthanum carbonate hydroxide, lanthanum oxycarbonate and method for producing and using the same
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
AU2011297901B2 (en) 2010-09-02 2014-07-31 Grunenthal Gmbh Tamper resistant dosage form comprising inorganic salt
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
JP6117249B2 (en) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Tamper resistant dosage forms comprising a pharmacologically active compound and an anionic polymer
RS57913B1 (en) 2012-04-18 2019-01-31 Gruenenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CN104349797B (en) 2012-06-12 2017-10-27 弗罗桑医疗设备公司 Dry hemostatic composition
BR112015000150A2 (en) 2012-07-06 2017-06-27 Egalet Ltd controlled release abuse deterrent pharmaceutical compositions
MX2015016112A (en) 2013-05-29 2016-03-31 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles.
BR112015029616A2 (en) 2013-05-29 2017-07-25 Gruenenthal Gmbh tamper-resistant dosage form with bimodal release profile
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
WO2015078891A1 (en) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
EP3079731B1 (en) 2013-12-11 2018-08-08 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
JP2016540798A (en) 2013-12-16 2016-12-28 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング A tamper resistant dosage form with a bimodal release profile produced by coextrusion
MX2016014738A (en) 2014-05-12 2017-03-06 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol.
CA2949422A1 (en) 2014-05-26 2015-12-03 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
US20160310429A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1018456A (en) 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
JPS5518694B2 (en) 1973-04-02 1980-05-21
US4330338A (en) 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4389393B1 (en) 1982-03-26 1985-10-22
DE3320583A1 (en) 1983-06-08 1984-12-13 Thomae Gmbh Dr K Novel pharmaceutical preparation forms of oral antidiabetic and process for their manufacture
AU591171B2 (en) 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
US4844984A (en) 1984-03-19 1989-07-04 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
JPH0246008B2 (en) * 1984-06-01 1990-10-12 Takada Seiyaku Kk Nifuejipinjizokuseiseizainoseizohoho
GB2170104A (en) 1985-01-30 1986-07-30 Warner Lambert Co Coated pharmaceutical dosage forms
ES8801121A1 (en) 1985-02-19 1988-01-01 Key Pharma Process for manufacturing a dosage unit for oral administration of potassium chloride.
US4898733A (en) 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US4892742A (en) 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
US4824675A (en) 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
WO1989009066A1 (en) 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
FI101344B (en) 1988-03-31 1998-06-15 Tanabe Seiyaku Co A process for preparing a preparation for which the controlled release of an active ingredient pharmaceutically '
AU621182B2 (en) 1989-01-30 1992-03-05 Alza Corporation Dosage form for administering calcium antagonist
JP2727009B2 (en) * 1989-03-10 1998-03-11 ダイト株式会社 Depot preparation
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec pharmaceutical preparation
IT1237904B (en) 1989-12-14 1993-06-18 Ubaldo Conte Tablets release at speed 'subsidiary of the active substances
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
GB9025372D0 (en) 1990-11-22 1991-01-09 Nat Res Dev Pharmaceutical dosage forms
US5683719A (en) 1990-11-22 1997-11-04 British Technology Group Limited Controlled release compositions
US5881926A (en) 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
JPH071001A (en) * 1993-06-21 1995-01-06 Nippon Steel Corp Stainless steel sheet for mirror finished surface material and its manufacture
US5478577A (en) 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5419917A (en) * 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
DE69506086T2 (en) 1994-02-23 1999-05-20 Bm Res As Controlled release composition
IL116674A (en) 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
EP0908181B8 (en) 1996-05-20 2009-04-15 Otsuka Pharmaceutical Co., Ltd. Remedy for rosacea
AT197900T (en) 1996-08-15 2000-12-15 Losan Pharma Gmbh Easy to swallow oral drug form
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
ID23503A (en) 1997-07-01 2000-04-27 Pfizer Sertralina salts and dosage forms of the slow off-sertralina
US6245357B1 (en) 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
JP4533531B2 (en) 1998-04-03 2010-09-01 ビーエム リサーチ エイ/エスBm Research A/S Controlled release composition
IL138990D0 (en) 1999-02-12 2001-11-25 Biostream Inc Matrices for drug delivery and methods for making and using the same
US6562375B1 (en) 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
US6534085B1 (en) 1999-09-23 2003-03-18 Bioresponse L.L.C. Phytochemicals for promoting weight loss
JP2003514019A (en) 1999-11-15 2003-04-15 スミスクライン・ビーチャム・コーポレイション Carvedilol methanesulfonate
US6491949B2 (en) 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
US6352721B1 (en) 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US20010036959A1 (en) 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions
US20020054911A1 (en) 2000-05-11 2002-05-09 Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi Novel oral dosage form for carvedilol
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
WO2002065834A2 (en) 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol
IN191028B (en) 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd Process for preparation of an oral controlled release pharmaceutical composition for once-a-day therapy for treatment and prophylaxis of cardiac and circulatory diseases
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
DK1429734T3 (en) 2001-09-21 2008-05-13 Egalet As Solid dispersions of carvedilol for controlled release
BR0213588A (en) 2001-09-28 2004-08-31 Mcneil Ppc Inc Modified release dosage
WO2004041252A1 (en) 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
US8298581B2 (en) 2003-03-26 2012-10-30 Egalet A/S Matrix compositions for controlled delivery of drug substances
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
CA2533165A1 (en) 2003-07-21 2005-01-27 Bio-Dar Ltd. Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention
WO2005027878A1 (en) 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Delayed released dosage forms
WO2005065654A2 (en) 2003-12-31 2005-07-21 Alpharma, Inc. Rosiglitazone formulations
CN101188999B (en) 2005-06-03 2012-07-18 尹格莱特股份有限公司 A pharmaceutical delivery system for delivering active component dispersed in dispersion medium

Also Published As

Publication number Publication date
DK1067910T3 (en) 2004-10-04
US20050089569A1 (en) 2005-04-28
US7883722B2 (en) 2011-02-08
CA2327685C (en) 2008-11-18
JP2002510616A (en) 2002-04-09
CA2327685A1 (en) 1999-10-14
ES2221370T3 (en) 2004-12-16
EP1067910A1 (en) 2001-01-17
DE69917618T2 (en) 2005-06-23
JP4533531B2 (en) 2010-09-01
WO1999051208A1 (en) 1999-10-14
EP1067910B1 (en) 2004-05-26
DE69917618D1 (en) 2004-07-01
AU3024399A (en) 1999-10-25

Similar Documents

Publication Publication Date Title
DE69806084T2 (en) controlled Radikalpolymerisatonsverfahren
DK1139739T3 (en) Agrochemical compositions
DE60011065D1 (en) Electronically controlled throttle
DE69904058D1 (en) Glyphosate formulation
DZ2739A1 (en) A polyethylene composition.
DE69921867D1 (en) microbicidal composition
NO327999B1 (en) Sustained release formulations
DE69707907T2 (en) herbicidal composition
DE69726729D1 (en) Fungicidal agents with improved bioavailability
DE69826289D1 (en) Microencapsulated compositions with controlled release ngf
AT254928T (en) Stabilized composition having nootropic active ingredients
AT231390T (en) A sustained release
AR026045A1 (en) Prolonged release formulations derivatives eritromocina
DE69523518D1 (en) Antimicrobial oral composition
DE69423582D1 (en) A pharmaceutical composition with controlled release of active ingredient
DE59710089D1 (en) Evaporation dispenser
DE69801048D1 (en) Fungicidal triazolopyrimidines-trifluorophenyl
DE69802810T2 (en) Solid medicinal preparation
DE69900162T2 (en) A medicament comprising oxaliplatin
DE69803907D1 (en) Fungicides 2-methoxybenzophenones
AT251383T (en) Formulations content with hihem ammoniumglyphosate-
AT167174T (en) Ready-hardening grout composition
NO985643D0 (en) antimicrobial compositions
DK0839525T3 (en) The prolonged release preparation
DE69919647D1 (en) Optically active fungicidal trifluoromethylalkylamino-triazolopyrimidines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1067910

Country of ref document: EP